Showing results (231-240 of 270) with videos related to
Sort By:
Pageof 27
Nuclear Medicine Communications|March 27, 1999
Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosisM Dietlein, B Krug, W Groth, et al.Acta Radiologica (Stockholm, Sweden : 1987)|October 4, 2000
Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methodsB Krug, M Dietlein, W Groth, et al.Nuklearmedizin. Nuclear Medicine|December 22, 1999
[Synthesis of tumor affinity label Yb-169- and Y-90- porphyrin complexes and animal experimental investigations with various Yb-169-porphyrins]K Schomäcker, M I Gaidouk, V D Rumyantseva, et al.Journal of the American College of Cardiology|September 19, 1998
Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: importance of infarct location adjusted thresholdsC A Schneider, E Voth, S Gawlich, et al.Nuklearmedizin. Nuclear Medicine|August 19, 2004
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 2)]M Dietlein, J Dressler, J Farahati, et al.Nuklearmedizin. Nuclear Medicine|December 9, 2004
[Guideline for radioiodine therapy for benign thyroid diseases (version 3)]M Dietlein, J Dressler, F Grünwald, et al.Nuklearmedizin. Nuclear Medicine|September 12, 2006
Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004M Schmidt, T Simon, B Hero, et al.Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Guideline for radioiodine therapy for benign thyroid diseases (version 4)]M Dietlein, J Dressler, F Grünwald, et al.American Heart Journal|March 1, 1992
Chronic myocardial infarction: assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile SPECTF M Baer, K Smolarz, M Jungehülsing, et al.Nuklearmedizin. Nuclear Medicine|December 6, 2008
[FDG-PET in Hodgkin lymphoma]C Kobe, M Dietlein, C Mauz-Körholz, et al.Pageof 27